| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
0.0003 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
0.0007 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
0.002 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
| mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.003 |